SEC Form 4 · accession 0001171843-15-005772
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Hague
Officer — Chief Commercial Officer
Period of report
Oct 26, 2015
Accepted (ET)
Oct 28, 2015 · 4:18 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 26, 2015 | A | 21,000 | $0.00 | A | 21,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted stock awards vest in four equal annual installments beginning October 26, 2016.